Sharon Lamb

Subscribe to Sharon Lamb's Posts
Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector. She advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies. Read Sharon Lamb's full bio.

UK Healthcare Waiting Lists: Will Choice Make a Difference?

By on Jan 11, 2024
Posted In Employee Benefits, Health and Welfare Plans

How can the independent sector and choice make a dent in reversing the increasingly high number of United Kingdom healthcare patients waiting for treatment? In this LaingBuisson News article, Sharon Lamb examines the latest waiting time data and offers perspective on potential solutions. Read more here.

Continue Reading

Health Data in the EU and UK: Regulatory Trends and Developments

By , , , and on Apr 25, 2023
Posted In Digital Health, Employee Benefits, Health and Welfare Plans

With the General Data Protection Regulation (GDPR) resulting in a rise in enforcement incidents, it is prudent for organizations operating in the health and life sciences industries across the United Kingdom, European Union (EU) and other European Economic Area (EEA) nations to assess their responsibilities regarding the gathering and handling of health data. Major Points:...

Continue Reading

Brexit and COVID-19: Changes to the Regulation of Medicines

By , and on Apr 28, 2021
Posted In Employee Benefits, Health and Welfare Plans

The combination of the Coronavirus (COVID-19) pandemic and the imminent end of the Brexit transition period means a fast-changing regulatory environment for medicines. In October 2020, the UK Government made changes to the regulation of medicines for COVID-19 and influenza. The regulations set out changes for the temporary authorisation of medicines (including COVID-19 vaccines) and...

Continue Reading




Top ranked chambers 2022
US leading firm 2022